Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.23
-0.3350-0.75%
Volume:3.52M
Turnover:156.77M
Market Cap:197.46B
PE:11.05
High:44.82
Open:44.60
Low:44.22
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.47
T/O Rate:0.11%
Dividend:1.72
Dividend Rate:3.89%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.06
PE(LYR):12.21

Loading ...

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Reuters
·
Sep 07

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

TIPRANKS
·
Sep 07

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Movement Alert|Novo-Nordisk A/S Falls 3.01% in Regular Trading, Next-Gen Weight-Loss Drug Trial Results Trail Eli Lilly Zepbound

Market Focus
·
Sep 04

Sector Update: Healthcare

MT Newswires Live
·
Sep 04

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live
·
Sep 04

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Sep 02

Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?

TradingKey
·
Sep 02

Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call

TIPRANKS
·
Sep 02

Movement Alert|Novo-Nordisk A/S Rises 3.08% in Regular Trading, Oral Weight-Loss Drug Marketing Application Accepted in China

Market Focus
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Reuters
·
Sep 01

New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management

Stock News
·
Sep 01

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Sep 01

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 01

Novo Nordisk Advances DKK 15 Billion Share Buyback Programme Through Late August 2026

TIPRANKS
·
Aug 31

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Novo Nordisk A/S Series B Stock Rises Friday

Dow Jones
·
Aug 29